These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1120 related articles for article (PubMed ID: 8018090)

  • 21. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
    Osada E; Murai T; Ishizaka Y; Sanai K
    Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. General pharmacology of the new antiviral agent SK 1899.
    Ryu KH; Rhee HI; Jung I; Kim TS; Lee SJ; Im GJ; Lee N; Ryu DH; Kim YW; Kim JJ; Chang K; Lee BH; Shin HS; Kim EJ; Kim KH; Kim DK
    Arzneimittelforschung; 2000 Apr; 50(4):395-403. PubMed ID: 10800640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. General pharmacological properties of cilostazol, a new antithrombotic drug. Part II: Effect on the peripheral organs.
    Shintani S; Watanabe K; Kawamura K; Mori T; Tani T; Toba Y; Sasabe H; Nakagiri N; Hongoh O; Fujita S
    Arzneimittelforschung; 1985; 35(7A):1163-72. PubMed ID: 3000392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacological studies of guanabenz. Effects on the peripheral nervous and other organ systems].
    Ohata K; Murata T; Sakamoto H; Kohno S; Hojo M; Yoshida Y; Nagasaka Y; Akimoto Y; Shimada A; Teramoto N; Tatsumi H
    Nihon Yakurigaku Zasshi; 1983 Jan; 81(1):59-78. PubMed ID: 6852682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. General pharmacological properties of YJA20379-8, a new H+/K(+)-ATPase inhibitor with anti-ulcer activities.
    Lee EB; Cho SI; Chang HO; Chang MS; Kim KB; Lee SB; Choi WS
    Arzneimittelforschung; 2001; 51(8):659-66. PubMed ID: 11556127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single dose toxicity study of the new cognition-enhancing agent nefiracetam in mice, rats and dogs.
    Sugawara T; Kato M; Furuhama K; Inage F; Suzuki N; Takayama S
    Arzneimittelforschung; 1994 Feb; 44(2A):211-3. PubMed ID: 8018091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. General pharmacology of beraprost sodium. 2nd communication: effect on the autonomic, cardiovascular and gastrointestinal systems, and other effects.
    Murata T; Murai T; Kanai T; Ogaki Y; Sanai K; Kanda H; Sato S; Kajikawa N; Umetsu T; Matsuura H
    Arzneimittelforschung; 1989 Aug; 39(8):867-76. PubMed ID: 2510743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antihypertensive and general pharmacological properties of budralazine.
    Chiba T; Shibamura S; Tanaka M; Yamasaki T; Hashimoto H; Kurebayashi Y; Kasai Y; Ryokawa Y; Tamura K; Hirohashi M; Akashi A
    Arzneimittelforschung; 1981; 31(7):1080-7. PubMed ID: 7023495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. General pharmacology of [2,2-dimethyl-6-(4-chlorophenyl)-7-phenyl-2,3- dihydro-1H-pyrrolizine-5-yl]-acetic acid in experimental animals.
    Algate DR; Augustin J; Atterson PR; Beard DJ; Jobling CM; Laufer S; Munt PL; Tries S
    Arzneimittelforschung; 1995 Feb; 45(2):159-65. PubMed ID: 7710439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. General pharmacology of cis-malonato[4R,5R)-4,5-bis-(aminomethyl)-2-isopropyl-1,3- dioxolane]platinum(II).
    Kim DK; Ahn JS; Ryu G; Kim KH; Park CW; Kim MS; Chung MH; Shin SG; Suh YH; Kim YS
    Arzneimittelforschung; 1994 Sep; 44(9):1080-8. PubMed ID: 7986249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. General pharmacological properties of YJA 20379-1, a novel proton pump inhibitor with antiulcer activities.
    Lee EB; Cho SI; Cheon SA; Chang MS; Kim KB; Sohn SK; Chung YK
    Arzneimittelforschung; 1999 Dec; 49(12):1018-24. PubMed ID: 10635448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. General pharmacology of the novel angiotensin converting enzyme inhibitor benazepril hydrochloride. Effects on cardiovascular, visceral and renal functions and on hemodynamics.
    Yamamoto S; Takemori E; Hasegawa Y; Kuroda K; Nakao K; Inukai T; Sakonjyo H; Nishimura T; Nishimori T
    Arzneimittelforschung; 1991 Sep; 41(9):913-23. PubMed ID: 1796919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigenicity study of the new cognition-enhancing agent nefiracetam.
    Wagai N; Yamaguchi F; Hasegawa T; Takayama S
    Arzneimittelforschung; 1994 Feb; 44(2A):247-50. PubMed ID: 8018098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [General pharmacology of traxanox sodium. I. Effects on the central, somatic, and autonomic nervous systems, digestive system, urologic organs, and reproductive system].
    Goto K; Osuga K; Haga K; Tsumagari T
    Nihon Yakurigaku Zasshi; 1983 May; 81(5):343-63. PubMed ID: 6629211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [General pharmacology of T-2588, a new oral cephem antibiotic].
    Hirai S; Kodama T; Hiraiwa T; Abe N; Arai H; Ono S; Omori M; Nakada Y; Hashiba K; Tanada K
    Jpn J Antibiot; 1986 Apr; 39(4):958-78. PubMed ID: 3761550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. General pharmacology studies on beta-domain deleted recombinant factor VIII.
    Lee JH; Kim HW; Kwon YB; Kang MS; Choi DW; Na JH; Kwon OK; Youn HJ; Han HJ; Byun TH; Park SY; Chun BH; Pyun JH; An GH; Lee YJ; Cho MH
    Arzneimittelforschung; 2000 Jan; 50(1):86-92. PubMed ID: 10683720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [General pharmacology of T-3761, a new oral quinolone antibacterial agent (2). Effect on the respiratory and cardiovascular systems, autonomic nervous system and other functions].
    Furuhata K; Hiraiwa T; Terashima N; Arai H; Ono S; Hashiba K; Maekawa M; Kitamura K; Nakada Y; Mori Y
    Jpn J Antibiot; 1995 May; 48(5):706-32. PubMed ID: 7637205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reproductive toxicity studies of the new cognition-enhancing agent nefiracetam in rats and rabbits.
    Watanabe T; Matsuhashi K; Shimada M; Harada S; Tawara K; Takayama S
    Arzneimittelforschung; 1994 Feb; 44(2A):239-42. PubMed ID: 8018096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system.
    Hirotsu I; Kihara T; Nakamura S; Hattori Y; Hatta M; Kitakaze Y; Takahama K; Hashimoto Y; Miyata T; Ishihara T
    Arzneimittelforschung; 1988 Oct; 38(10):1398-409. PubMed ID: 3196380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.